VENLAFAXINE

Clinical Indication

Depression (All doses)

Comments

SBAR: Change to Venlafaxine Shared Care Arrangements

Dose-related increases in blood pressure have been commonly reported with venlafaxine. All patients should be carefully screened for high blood pressure and pre-existing hypertension should be controlled before initiation of treatment. Blood pressure should be reviewed periodically, after initiation of treatment and after dose increases.

Date of classification

December 2025